Skip to main content

Table 1 Epidemiological and clinical characteristics of 81 HD patients

From: Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients

Age (years) 59.8 ± 15.7
Male 52 (64.2)
Dialysis duration (months) 66.2 ± 53.9
Diabetes mellitus 17 (21)
Hypertension 57 (70.4)
History of CVD 30 (37)
Smoking 25 (30.9)
Statins 29 (35.8)
Anti-hypertensives 57 (70,4)
Anti-HPTH treatment 46 (56.8)
ESA 73 (90,1)
Intravenous iron 73 (90,1)
BMI (kg/m2) 24.6 ± 4.1
SAP (mmHg) 136.1 ± 18.9
DAP (mmHg) 83.6 ± 12.1
PP (mmHg) 52.9 ± 13.8
MAP (mmHg) 100.9 ± 13.4
  1. Values are expressed as mean±SD or numbers (%) as appropriate.
  2. CVD cardiovascular disease, DAP diastolic arterial pressure, ESA erythropoiesis stimulating agent, HPTH hyperparathyroidism, MAP mean arterial pressure, PP pulse pressure, SAP systolic arterial pressure.